- Home
- ROIV vs AGI Comparison
ROIV vs AGI Comparison
Compare ROIV & AGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AGI
- Stock Information
- Founded
- ROIV 2014
- AGI 2003
- Country
- ROIV United Kingdom
- AGI Canada
- Employees
- ROIV N/A
- AGI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AGI Precious Metals
- Sector
- ROIV Health Care
- AGI Basic Materials
- Exchange
- ROIV Nasdaq
- AGI Nasdaq
- Market Cap
- ROIV 8.4B
- AGI 7.2B
- IPO Year
- ROIV N/A
- AGI 1999
- Fundamental
- Price
- ROIV $12.30
- AGI $18.10
- Analyst Decision
- ROIV Strong Buy
- AGI Strong Buy
- Analyst Count
- ROIV 10
- AGI 5
- Target Price
- ROIV $17.33
- AGI $20.85
- AVG Volume (30 Days)
- ROIV 4.2M
- AGI 2.1M
- Earning Date
- ROIV 08-08-2024
- AGI 10-23-2024
- Dividend Yield
- ROIV N/A
- AGI 0.55%
- EPS Growth
- ROIV N/A
- AGI 22.21
- EPS
- ROIV 5.65
- AGI 0.50
- Revenue
- ROIV $158,303,000.00
- AGI $1,121,000,000.00
- Revenue This Year
- ROIV $45.51
- AGI $28.31
- Revenue Next Year
- ROIV $42.29
- AGI $11.42
- P/E Ratio
- ROIV $2.18
- AGI $38.26
- Revenue Growth
- ROIV 101.44
- AGI 17.01
- 52 Week Low
- ROIV $8.25
- AGI $10.78
- 52 Week High
- ROIV $13.24
- AGI $20.24
- Technical
- Relative Strength Index (RSI)
- ROIV 65.79
- AGI 45.10
- Support Level
- ROIV $11.50
- AGI $18.17
- Resistance Level
- ROIV $12.60
- AGI $18.63
- Average True Range (ATR)
- ROIV 0.35
- AGI 0.43
- MACD
- ROIV 0.04
- AGI -0.22
- Stochastic Oscillator
- ROIV 79.19
- AGI 6.33
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has three operating mines in North America: Young-Davidson and Island Gold mines operate in Canada and the Mulatos and in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.